The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease
Open accessAbstract
Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of renal failure and is characterized by the formation of many fluid-filled cysts in the kidneys. It is a systemic disorder that is caused by mutations in PKD1 or PKD2. Homozygous inactivation of these genes at the cellular level, by a 'two-hit' mechanism, has been implicated in cyst formation but does not seem to be the sole mechanism for cystogenesis. We have generated a novel mouse model with a hypomorphic Pkd1 allele, Pkd1(nl), harbouring an intronic neomycin-selectable marker. This selection cassette causes aberrant splicing of intron 1, yielding only 13-20% normally spliced Pkd1 transcripts in the majority of homozygous Pkd1(nl) mice. Homozygous Pkd1(nl) mice are viable, showing bilaterally enlarged polycystic kidneys. This is in contrast to homozygous knock-out mice, which are embryonic lethal, and heterozygous knock-out mice that show only a very mild cystic phenotype. In addition, homozygous Pkd1(nl) mice showed dilatations of pancreatic and liver bile ducts, and the mice had cardiovascular abnormalities, pathogenic features similar to the human ADPKD phenotype. Removal of the neomycin selection-cassette restored the phenotype of wild-type mice. These results show that a reduced dosage of Pkd1 is sufficient to initiate cystogenesis and vascular defects and indicate that low Pkd1 gene expression levels can overcome the embryonic lethality seen in Pkd1 knock-out mice. We propose that in patients reduced PKD1 expression of the normal allele below a critical level, due to genetic, environmental or stochastic factors, may lead to cyst formation in the kidneys and other clinical features of ADPKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5860 · Cited by 1,125
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Wilson, P. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra022161 · Cited by 916
Dise, T. E. P. K. (1994) · Cell · doi:10.1016/0092-8674(94)90137-6 · Cited by 903
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents
Hanaoka, K., Qian, F., Boletta, A., Bhunia, A. K., Piontek, K., Tsiokas, L., Sukhatme, V. P., Guggino, W. B., & Germino, G. G. (2000) · Nature · doi:10.1038/35050128 · Cited by 818
Conditional control of gene expression in the mouse
Lewandoski, M. (2001) · Nature Reviews Genetics · doi:10.1038/35093537 · Cited by 781
Gattone, V. H., Wang, X., Harris, P. C., & Torres, V. E. (2003) · Nature Medicine · doi:10.1038/nm935 · Cited by 670
Comparison of phenotypes of polycystic kidney disease types 1 and 2
Hateboer, N., v Dijk, M. A., Bogdanova, N., Coto, E., Saggar-Malik, A. K., Millan, J. L. S., Torra, R., Breuning, M., & Ravine, D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03495-3 · Cited by 628
Self-citationQian, F., Watnick, T. J., Onuchic, L. F., & Germino, G. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81793-6 · Cited by 615
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Wu, G., D'Agati, V., Cai, Y., Markowitz, G., Park, J. H., Reynolds, D. M., Maeda, Y., Le, T. C., Hou, H., Kucherlapati, R., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81570-6 · Cited by 570
Brook-Carter, P. T., Peral, B., Ward, C. J., Thompson, P., Hughes, J., Maheshwar, M. M., Nellist, M., Gamble, V., Harris, P. C., & Sampson, J. R. (1994) · Nature Genetics · doi:10.1038/ng1294-328 · Cited by 510
Self-citationEffective treatment of an orthologous model of autosomal dominant polycystic kidney disease
Torres, V. E., Wang, X., Qian, Q., Somlo, S., Harris, P. C., & Gattone, V. H. (2004) · Nature Medicine · doi:10.1038/nm1004 · Cited by 482
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD 2
Tsiokas, L., Kim, E., Arnould, T., Sukhatme, V. P., & Walz, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6965 · Cited by 476
Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation
Lu, W., Peissel, B., Babakhanlou, H., Pavlova, A., Geng, L., Fan, X., Larson, C., Brent, G., & Zhou, J. (1997) · Nature Genetics · doi:10.1038/ng1097-179 · Cited by 451
González-Perrett, S., Kim, K., Ibarra, C., Damiano, A. E., Zotta, E., Batelli, M., Harris, P. C., Reisin, I. L., Arnaout, M. A., & Cantiello, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1182 · Cited by 447
Cardiac defects and renal failure in mice with targeted mutations in Pkd2
Wu, G., Markowitz, G. S., Li, L., D'Agati, V. D., Factor, S. M., Geng, L., Tibara, S., Tuchman, J., Cai, Y., Hoon Park, J., et al. (2000) · Nature Genetics · doi:10.1038/71724 · Cited by 399
Polycystin 1 is required for the structural integrity of blood vessels
Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K., & Arnaout, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040550097 · Cited by 338
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
Boulter, C., Mulroy, S., Webb, S., Fleming, S., Brindle, K., & Sandford, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211191098 · Cited by 309
Expression of Podocyte-Associated Molecules in Acquired Human Kidney Diseases
Koop, K., Eikmans, M., Baelde, H. J., Kawachi, H., de Heer, E., Paul, L. C., & Bruijn, J. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000078803.53165.c9 · Cited by 300
Self-citationGenetic Heterogeneity of Polycystic Kidney Disease in Europe1
Peters, D. J. M., & Sandkuijl, L. A. (2015) · Contributions to Nephrology · doi:10.1159/000421651 · Cited by 282
Self-citationAutosomal Dominant Polycystic Kidney Disease—More Than a Renal Disease
Gabow, P. A. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80051-5 · Cited by 260
Ward, C. J., Turley, H., Ong, A. C., Comley, M., Biddolph, S., Chetty, R., Ratcliffe, P. J., Gattner, K., & Harris, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1524 · Cited by 245
Self-citationModeling stochastic gene expression: Implications for haploinsufficiency
Cook, D. L., Gerber, A. N., & Tapscott, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15641 · Cited by 242
Murine models of polycystic kidney disease: molecular and therapeutic insights
Guay-Woodford, L. M. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00195.2003 · Cited by 192
PEI, Y., WATNICK, T., HE, N., WANG, K., LIANG, Y., PARFREY, P., GERMINO, G., & GEORGE-HYSLOP, P. S. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071524 · Cited by 192
Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells
Qian, Q., Hunter, L. W., Li, M., Marin-Padilla, M., Prakash, Y. S., Somlo, S., Harris, P. C., Torres, V. E., & Sieck, G. C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg190 · Cited by 181
Pritchard, L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2617 · Cited by 164
The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology
Verroust, P. J., Birn, H., Nielsen, R., Kozyraki, R., & Christensen, E. I. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00501.x · Cited by 161
Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease
Wu, G., Tian, X., Nishimura, S., Markowitz, G. S., D'Agati, V., Park, J. H., Yao, L., Li, L., Geng, L., Zhao, H., et al. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.16.1845 · Cited by 143
EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats
Torres, V. E., Sweeney, W. E., Wang, X., Qian, Q., Harris, P. C., Frost, P., & Avner, E. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00256.x · Cited by 135
Fodde, R., & Smits, R. (2002) · Science · doi:10.1126/science.1077707 · Cited by 132
Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations
Watnick, T. J., He, N., Wang, K., Liang, Y., Parfrey, P. S., Hefferton, D., George‐Hyslop, P. S., Germino, G. G., & Pei, Y. (2000) · Nature Genetics · doi:10.1038/75981 · Cited by 130
Polycystic kidney disease and intracranial aneurysms
Wakabayashi, T., Fujita, S., Ohbora, Y., Suyama, T., Tamaki, N., & Matsumoto, S. (1983) · Journal of neurosurgery · doi:10.3171/jns.1983.58.4.0488 · Cited by 111
Koptides, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.447 · Cited by 104
Reeders, S. T. (1992) · Nature Genetics · doi:10.1038/ng0792-235 · Cited by 99
Autosomal dominant polycystic kidney disease: modification of disease progression
Peters, D. J. M., & Breuning, M. H. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06531-x · Cited by 96
Self-citationPolycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue
Ong, A. C. M., Harris, P. C., Davies, D. R., Pritchard, L. E., Rossetti, S., Biddolph, S. C., Vaux, D. J., Migone, N., & Ward, C. J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00659.x · Cited by 93
Self-citationExtrarenal manifestations of ADPKD
Perrone, R. D. (1997) · Kidney International · doi:10.1038/ki.1997.276 · Cited by 82
Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes
Guillaume, R., & Trudel, M. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00257-4 · Cited by 39
Cited by
Autosomal dominant polycystic kidney disease
Torres, V. E., Harris, P. C., & Pirson, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60601-1 · Cited by 1,550
Bergmann, C., Guay-Woodford, L. M., Harris, P. C., Horie, S., Peters, D. J. M., & Torres, V. E. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0047-y · Cited by 807
Self-citationHarris, P. C., & Torres, V. E. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.101707.125712 · Cited by 801
Autosomal dominant polycystic kidney disease
Cornec-Le Gall, E., Alam, A., & Perrone, R. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32782-x · Cited by 624
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
Hopp, K., Ward, C. J., Hommerding, C. J., Nasr, S. H., Tuan, H.-F., Gainullin, V. G., Rossetti, S., Torres, V. E., & Harris, P. C. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64313 · Cited by 442
“gressive cystic disease in the kidney, liver, and pancreas, despite the presence of some functional polycystin (40, 41, 58).”
InfluentialSelf-citation
Metadata
- Authors
- Leeuwen, I. S. L.-V., Dauwerse, J. G., Baelde, H. J., Leonhard, W. N., van de Wal, A., Ward, C. J., Verbeek, S., DeRuiter, M. C., Breuning, M. H., de Heer, E., & Peters, D. J. M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-12-15
- Volume
- 13
- Issue
- 24
- Pages
- 3069-3077
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2123474135
- Cited by
- 352
- References
- 40
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.